(Q40570813)

21 September 2017

title

Possible contribution of interferon-alpha to febrile seizures in influenza (English)

1 reference

21 September 2017

Tatsuo Masuyama

1

1 reference

21 September 2017

Muneaki Matsuo

2

1 reference

21 September 2017

Tomohiro Ichimaru

3

1 reference

21 September 2017

Kiyohisa Ishii

4

1 reference

21 September 2017

Katsunori Tsuchiya

5

1 reference

21 September 2017

Yuhei Hamasaki

6

1 reference

21 September 2017

publication date

1 October 2002

1 reference

21 September 2017

1 reference

21 September 2017

volume

27

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

289-292

1 reference

Neural-immune interactions in health and disease

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Elevated creatine phosphokinase levels associated with influenza A/Texas/1/77 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Epidemic influenza myopathy in Cincinnati in 1977.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Creatine Phosphokinase Measurements in Febrile Children

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Elevated serum creatine kinase. Following febrile seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Acute myopathy associated with influenza A/Texas/1/77 infection. Isolation of virus from a muscle biopsy specimen

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Isolation of influenza virus from muscle in myoglobinuric polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Infectivity of influenza B virus in cultured human muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

The first case of polymyositis associated with interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Symptomatic myopathy during interferon alfa therapy for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Seizures associated with low-dose alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Seizures during alpha interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Photosensitive seizures associated with interferon alfa-2a

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Seizures in children during interferon alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Interferon enhances the excitability of cultured neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

Interferon-alpha and transforming growth factor-beta 1 regulate corticotropin-releasing factor release from the amygdala: comparison with the hypothalamic response

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2802%2900452-6

7 January 2021

10.1016/S0887-8994(02)00452-6

Identifiers

DOI

1 reference

21 September 2017

1 reference